临床试验/NCT00518037

NCT00518037已完成不适用

Quality of Life in Patients With Nonmelanoma Skin Cancer

Northwestern University2 个研究点分布在 1 个国家目标入组 112 人开始时间: 2006年6月最近更新: 2021年12月6日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Northwestern University
入组人数: 112
试验地点: 2
主要终点: statistics from results of Skindex survey

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The goal of this study is to learn more about the physical discomfort, sensory impairment, depression, anxiety, and interference with relationships, family, and work associated with NMSC via survey questions.

详细描述

The purpose of this study is to learn more about the physical discomfort, sensory impairment, depression, anxiety, and interference with relationships, family, and work associated with NMSC via survey questions.

研究设计

研究类型: Observational
观察模型: Other
时间视角: Prospective

入排标准

性别: All
接受健康志愿者: 是

入选标准

•patients with nonmelanoma skin cancer
•18 years of age

排除标准

•non-English speakers

结局指标

主要结局

statistics from results of Skindex survey

时间窗: 1 hour to complete survey

次要结局

statistics from time-tradeoff utility survey(1 hour to complete survey)

研究者

发起方

Northwestern University

申办方类型

Other

责任方

Principal Investigator

主要研究者

Murad Alam

Professor in Dermatology, Otolaryngology - Head and Neck Surgery and Surgery-Organ Transplantation

Northwestern University

研究点 (2)

Loading locations...

相似试验

招募中

不适用

Quality of life research among melanoma patients that have been treated with immunotherapy, or targeted therapy and/or surgeryKwaliteit van LevenQuality of Life10040900

NL-OMON55207Antoni van Leeuwenhoek Ziekenhuis700

尚未招募

不适用

Melanoma patients and Quality of Life after active treatmentMelanoma (stage III/IV)

NL-OMON26948o sponsors, the study is investigator initiated500

已完成

不适用

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL InstrumentsCancerDermatologic Conditions

NCT02296450Memorial Sloan Kettering Cancer Center839

招募中

不适用

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.Kidney CancerHead Neck CancerBreast CancerGastric CancerMelanomaBladder CancerLung CancerSkin Cancer

NCT05878964Fondazione Policlinico Universitario Agostino Gemelli IRCCS420

已完成

不适用

NCT03134911Boehringer Ingelheim535